gmp
gmp

 

PharmaCompass Search Results for "SHIONOGI INC"

ADVANCE SEARCH :

    About 3564 results

    API Manufacturers

    Shionogi Inc DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Ex...

    Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 139-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages our science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, a...

    PipeLine Prospector

    Shionogi Inc | Drug Developments | Pipeline Prospector

    Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shionogi Inc

    API Manufacturers

    Shionogi & Co., Ltd DMF, CEP, Written Confirmations, FDF, Prices, Patents, Paten...

    DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News Shionogi & Co., Ltd
    Missing: inc

    Service Provider

    Tetra Therapeutics DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patent...

    Tetra Therapeutics, a clinical-stage biopharmaceutical company developing novel treatments for patients with cognitive impairment and memory loss, today announced it has entered into an expanded strategic alliance with Shionogi. The two companies will work together to develop and commercialize BPN14770 for the treatment of Alzheimer&rsquo...

    API Manufacturers

    ViiV Healthcare DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents &...

    ViiV Healthcare is a global specialist HIV company dedicated to delivering advances in treatment and care for people living with HIV. We are an independent pharmaceutical company established in 2009 by combining the power and expertise in the management of HIV from both GlaxoSmithKline (GSK) and Pfizer. Following a long-term collaboratio...
    Missing: inc

    APIs

    Peramivir DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclu...

    Peramivir is an experimental antiviral drug being developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir is supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. The drug has had a long history. An oral formulation was abandone...
    Missing: inc

    Intermediates

    CAS 229614-56-6 - Uses, DMF, Dossier, Manufacturer, Supplier, Licensing, Distrib...

    Peramivir is an experimental antiviral drug being developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir is supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. The drug has had a long history. An oral formulation was abandoned by ...
    Missing: inc

    Intermediates

    CAS 229614-55-5 - Uses, DMF, Dossier, Manufacturer, Supplier, Licensing, Distrib...

    Peramivir is an experimental antiviral drug being developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir is supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. The drug has had a long history. An oral formulation was abandoned by ...
    Missing: inc

    Intermediates

    CAS 330600-85-6 - Uses, DMF, Dossier, Manufacturer, Supplier, Licensing, Distrib...

    Peramivir is an experimental antiviral drug being developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir is supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. The drug has had a long history. An oral formulation was abandoned by ...
    Missing: inc

    Intermediates

    AKOS016007760 - Uses, DMF, Dossier, Manufacturer, Supplier, Licensing, Distribut...

    Peramivir is an experimental antiviral drug being developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir is supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. The drug has had a long history. An oral formulation was abandoned by ...
    Missing: inc

    What are you looking for?

    How can we help you?

    The request can't be empty
    Please read our Privacy Policy carefully
    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    How PharmaCompass Connections Work